Literature DB >> 11177539

Manipulation of the cytoplasmic and transmembrane domains alters cell surface levels of the coxsackie-adenovirus receptor and changes the efficiency of adenovirus infection.

W van't Hof1, R G Crystal.   

Abstract

Expression of the coxsackie-adenovirus receptor (CAR) is a critical determinant in cellular susceptibility to infection with adenovirus-based gene transfer vectors. This study is focused on the hypothesis that manipulation of the cytoplasmic tail and transmembrane regions of CAR can be used to change cell surface levels of CAR and, consequently, to alter the efficiency of Ad-mediated gene transfer. To accomplish this, Flag-tagged ([F]) human CAR ([F]CAR), [F]tailless-CAR (lacking the cytoplasmic tail), and [F]GPI-CAR (containing a GPI lipid anchor instead of the transmembrane and cytoplasmic regions) were exogenously expressed in CHO cells. Analysis of (125)I-labeled anti-Flag antibody binding to transfected cells revealed that [F]tailless-CAR and [F]GPI-CAR were expressed on the cell surface in 1.8- to 2.5-fold higher amounts than [F]CAR, while the total expression levels were similar. Infection with replication-deficient adenovirus encoding beta-galactosidase (Ad-betagal) demonstrated 1.5- to 2-fold higher levels of transgene expression in CHO cells expressing [F]tailless-CAR or [F]GPI-CAR, respectively, compared with cells containing [F]CAR. The form of CAR expressed did not affect the transport of fluorescent Cy3-Ad particles from the cell surface to the nuclear region. These observations indicate that transduction of target cells by Ad vectors can be optimized by increasing cell surface levels of CAR through functional deletion of the tail and membrane protein domains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11177539     DOI: 10.1089/104303401450933

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  Adenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.

Authors:  Lane K Law; Beverly L Davidson
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Adenoviral SERCA1 overexpression triggers an apoptotic response in cultured neonatal but not in adult rat cardiomyocytes.

Authors:  Guimei Wu; Xilin Long; José Marín-García
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

3.  Apical localization of the coxsackie-adenovirus receptor by glycosyl-phosphatidylinositol modification is sufficient for adenovirus-mediated gene transfer through the apical surface of human airway epithelia.

Authors:  R W Walters; W van't Hof; S M Yi; M K Schroth; J Zabner; R G Crystal; M J Welsh
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection.

Authors:  Jaclyn R Stonebraker; Danielle Wagner; Robert W Lefensty; Kimberlie Burns; Sandra J Gendler; Jeffrey M Bergelson; Richard C Boucher; Wanda K O'Neal; Raymond J Pickles
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Fatty acid modification of the coxsackievirus and adenovirus receptor.

Authors:  Wouter van't Hof; Ronald G Crystal
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.

Authors:  C P Rooney; G M Denning; B P Davis; D M Flaherty; J A Chiorini; J Zabner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia.

Authors:  Katherine J D A Excoffon; Nicholas D Gansemer; Matthew E Mobily; Philip H Karp; Kalpaj R Parekh; Joseph Zabner
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

8.  The coxsackie B virus and adenovirus receptor resides in a distinct membrane microdomain.

Authors:  Katherine J D Ashbourne Excoffon; Thomas Moninger; Joseph Zabner
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus.

Authors:  Jason C Steel; Brian J Morrison; Poonam Mannan; Mones S Abu-Asab; Oliver Wildner; Brian K Miles; Kevin C Yim; Vijay Ramanan; Gregory A Prince; John C Morris
Journal:  Virology       Date:  2007-08-28       Impact factor: 3.616

10.  Analysis of genetic heterogeneity in the HCAR adenovirus-binding Ig1 domain in a Caucasian Flemish population.

Authors:  Inge Thoelen; Griet Duson; Elke Wollants; Marc Van Ranst
Journal:  BMC Genet       Date:  2002-01-10       Impact factor: 2.797

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.